MENU

AVXL Stock Anavex Life Sciences (AVXL, $4.49) RSI Indicator left the overbought zone on May 15, 2024

A.I.dvisor
at Tickeron.com
05/16/24
Loading...
AVXL - Anavex Life Sciences Corp
RSI signal
Bearish Trend
Odds of DOWN Trend
Tickeron
RSI signal
Price: $4.49
Daily change: +$0.18 (+4.18%)
Daily volume: 1.5M
Capitalization: $380M
Industry: Biotechnology
This is a signal that AVXL's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options. A.I.dvisor looked back and found 30 similar cases where AVXL's RSI Indicator left the overbought zone, and in of them led to a successful outcome. Odds of Success:

AVXL's RSI Indicator is staying in overbought zone for 9 days

The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where AVXL's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVXL declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AVXL broke above its upper Bollinger Band on November 08, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2024. You may want to consider a long position or call options on AVXL as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AVXL just turned positive on October 28, 2024. Looking at past instances where AVXL's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

AVXL moved above its 50-day moving average on October 28, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AVXL crossed bullishly above the 50-day moving average on October 31, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AVXL advanced for three days, in of 260 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 203 cases where AVXL Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AVXL’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.247) is normal, around the industry mean (14.905). P/E Ratio (0.000) is within average values for comparable stocks, (98.894). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.944). AVXL has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (217.940).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVXL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
AVXL
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of innovative drug compounds

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
630 5th Avenue
Phone
+1 844 689-3939
Employees
40
Web
https://www.anavex.com